Table of Contents
Overview
New York, NY – July 04, 2025 – The US Medical Imaging Market size is expected to be worth around US$ 18.3 Billion by 2034 from US$ 11.1 Billion in 2024, growing at a CAGR of 5.1% during the forecast period 2025 to 2034.
The U.S. medical imaging market is poised for substantial growth, driven by increasing demand for early disease detection, rising geriatric population, and rapid technological advancements in imaging modalities. The market continues to evolve as healthcare providers adopt high-resolution imaging systems to enhance diagnostic accuracy and patient outcomes.
Medical imaging encompasses a range of diagnostic technologies, including X-ray, MRI, CT scan, ultrasound, and nuclear imaging. These modalities play a critical role in detecting and monitoring conditions such as cancer, cardiovascular diseases, neurological disorders, and musculoskeletal injuries. The integration of artificial intelligence (AI) and machine learning (ML) is further transforming the imaging landscape by improving image interpretation and workflow efficiency.
The market is also supported by favorable reimbursement policies, government initiatives promoting early diagnosis, and the expansion of outpatient imaging centers across the country. Key players in the U.S. medical imaging market include GE HealthCare, Siemens Healthineers, Philips Healthcare, and Canon Medical Systems, all of which continue to invest in research and innovation.
The U.S. medical imaging market is expected to maintain steady growth in the coming years as clinical demand rises and new technologies emerge. Increasing awareness about preventive healthcare and the need for precise diagnostics are likely to sustain long-term market expansion.
Key Takeaways
- In 2024, the U.S. medical imaging market was valued at approximately USD 11.1 billion and is projected to reach USD 18.3 billion by 2033, expanding at a compound annual growth rate (CAGR) of 5.1% during the forecast period.
- Based on modality, the market is segmented into X-rays, ultrasound, nuclear medicine scans, MRI scans, mammography, and CT scans. Among these, X-rays accounted for the largest market share in 2023, contributing approximately 34.5% of total revenue.
- By end-use, the market is categorized into hospitals, diagnostic imaging centers, and others. Hospitals dominated the segment in 2023, holding a substantial market share of 62.4%, attributed to higher patient volume and advanced imaging infrastructure.
Segmentation Analysis
- Rayus Radiology
- Radnet, Inc
- Novant Health
- Medica Group
- Inhealth Group
- Ezra
- Dignity Health
- Alliance Medical
Market Segments
- Modality Analysis: In 2023, the X-rays segment led the U.S. medical imaging market with a 34.5% share, driven by advancements in digital X-rays and fluoroscopy technologies. The growing prevalence of chronic diseases such as cardiovascular conditions and cancer has reinforced the role of X-rays as a key diagnostic tool. Increased adoption in both urban and rural areas, rising demand from outpatient and emergency care, and the development of portable devices continue to support the segment’s sustained growth.
- End-use Analysis: Hospitals dominated the end-use segment in 2023, accounting for 62.4% of the market share. This dominance is attributed to significant investments in advanced imaging systems like MRI, CT, and X-ray technologies aimed at enhancing diagnostic accuracy. The growing patient base, focus on early detection, and rising preference for outpatient procedures have further driven hospital-based imaging services. Moreover, the integration of artificial intelligence (AI) in diagnostics is expected to strengthen imaging capabilities across hospital settings.
Key Player Analysis
Leading players in the U.S. medical imaging market are actively pursuing growth through strategic investments in advanced technologies, geographic expansion, and collaborative partnerships. A key focus is placed on the development of portable and AI-powered imaging systems to meet the rising demand for fast and accurate diagnostics. These companies are also broadening their service portfolios and enhancing user experience to strengthen market competitiveness.
Expanding into new geographic regions, particularly emerging markets, enables companies to access untapped growth opportunities and diversify their customer base. Furthermore, collaborations with academic institutions and biotechnology firms support innovation by providing access to advanced research and development resources.
GE HealthCare stands out as a leading participant in the U.S. medical imaging market, offering an extensive range of imaging technologies, including MRI, CT, ultrasound, and molecular imaging systems. The company places a strong emphasis on integrating artificial intelligence and cloud-based platforms to improve diagnostic precision and streamline clinical workflows.
With a strong domestic presence, GE HealthCare generates a significant share of its revenue from the U.S. market. Continued investment in research and development remains a strategic priority, reinforcing its position as an innovation leader within the industry.
Emerging Trends
Emerging Trends in US Medical Imaging: The integration of artificial intelligence (AI) and machine learning into imaging workflows has accelerated. AI algorithms are increasingly being cleared through the FDA’s Digital Health Center of Excellence, enabling automated image interpretation, lesion detection, and workflow prioritization in modalities such as CT, MRI, and mammography. The growth of AI-enabled software-as-a-medical-device (SaMD) is expected to enhance diagnostic accuracy and reduce radiologist workload.
A movement toward standardized, interoperable health data has been advanced through the United States Core Data for Interoperability (USCDI) and proposed Health IT rules. These initiatives mandate the adoption of common data elements and FHIR-based APIs, facilitating seamless exchange of imaging reports and metadata across electronic health record systems. As a result, real-time access to prior imaging and structured reporting is becoming more widespread.
Patient safety and radiation-dose management have been emphasized by the CDC and professional societies. Ionizing-radiation dose-reduction protocols such as low-dose CT techniques and stricter guidelines for justifying imaging use have been implemented to minimize long-term cancer risk. Dose-monitoring registries are being adopted at major centers to track cumulative radiation exposure per patient.
In ambulatory settings, imaging utilization among older adults has continued to rise. Between 1996 and 2006, ambulatory visit rates for ultrasound, MRI, CT, and PET scans among patients aged 55–64 years increased substantially, reflecting broader access to advanced diagnostic services outside hospital inpatient settings. This shift has been driven by expanded reimbursement policies and the growth of outpatient imaging centers.
Use Cases
- Emergency Department Diagnostics: In 2018, imaging studies were integral to emergency care: X-rays were performed in 46,642 visits (35.9 % of ED encounters), CT scans in 25,437 visits (19.6 %), ultrasound in 7,119 visits (5.5 %), and MRI scans in 1,322 visits (1.0 %). These modalities supported rapid evaluation of trauma, stroke, and acute abdominal conditions, enabling time-sensitive decision making.
- Ambulatory Monitoring and Follow-Up: Ambulatory clinics have increasingly adopted advanced imaging for chronic disease management. From 1996 to 2006, the rate of ultrasound, MRI, CT, and PET use in outpatient visits among 55–64-year-olds rose markedly, underscoring the role of imaging in monitoring cardiovascular disease, cancer surveillance, and musculoskeletal disorders outside hospital settings.
- Vision and Eye Health Screening: Through the Vision and Eye Health Surveillance System, it is reported that a growing proportion of Medicare beneficiaries receive routine imaging tests—such as optical coherence tomography and fundus photography for early detection of glaucoma and diabetic retinopathy. These services are captured in claims and EHR data, supporting population-level surveillance of eye disease.
- AI-Driven Teleradiology: AI-enabled platforms are being employed to support remote image interpretation in underserved regions. Under FDA’s pilot programs for digital health precertification, teleradiology solutions integrating deep-learning algorithms have been validated for stroke detection on CT scans, reducing time to diagnosis by up to 30 % in some hospitals. This use case exemplifies the delivery of expert analysis where on-site radiologists are scarce.
Conclusion
The U.S. medical imaging market is expected to witness sustained growth driven by rising clinical demand, an aging population, and continuous technological innovation. The integration of artificial intelligence, expansion of outpatient imaging centers, and supportive regulatory initiatives are significantly transforming diagnostic workflows and enhancing patient outcomes.
With strong investments from key players such as GE HealthCare and Siemens Healthineers, the market is evolving toward greater efficiency and precision. Use cases across emergency, ambulatory, and preventive care settings highlight imaging’s expanding role in healthcare delivery. Continued advancements and accessibility are poised to strengthen the market’s position in the coming decade.
Discuss your needs with our analyst
Please share your requirements with more details so our analyst can check if they can solve your problem(s)
